Skip to main content

Molecular Imaging Market Size Worth USD 10.71 Billion by 2027, Growing Geriatric Population is One of the Significant Factors Influencing the Industry Growth, says Emergen Research

Vancouver, British Columbia--(Newsfile Corp. - April 12, 2021) - The global molecular imaging market is projected to be worth USD 10.71 Billion by 2027, according to a current analysis by Emergen Research. The molecular imaging market is observing a rapid growth attributed to a growing geriatric population. The growing geriatric population is a major factor stimulating market demand. It has been estimated that by 2050 approximately 16.0% of the global population will be aged more than 65 years, which is expected to increase five-fold since 1950. Elderly people suffer from various complications, including respiratory diseases, cardiovascular diseases, and neurological diseases, thereby fuelling market molecular imaging demand.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/271

Growing technological advancements and increased investments in cancer imaging are causative of the rapid growth of the molecular imaging market. Hologic, Inc., in November 2019, received approval from the US Food and Drug Administration (FDA) for its 3DQuorum™ Imaging Technology, driven by Genius AI™. The technology works simultaneously with Hologic's Clarity HD™ high-resolution molecular imaging technology and helps radiologists reduce tomosynthesis image volume by 66.0%.

Key participants include:

Canon Inc., Digirad Corporation, General Electric Company, PerkinElmer Inc., Siemens Healthineers Inc., Bruker Corporation, Cardinal Health, Thermo Fisher Scientific, Advanced Accelerator Applications, and DDD-Diagnostics A/S, among others.

Key Highlights From The Report

  • In July 2019, Agilent Technologies Inc. made an announcement about the signing of an agreement to buy BioTek Instruments, a private firm, for USD 1.17 billion. BioTek is involved in designing, producing, and distributing groundbreaking life science equipment, including cell imaging systems.
  • Breast cancer is the most commonly occurring cancer type in women, with more than 2 million new breast cancer cases in 2018. The global breast cancer survival rates vary greatly, ranging from around 80% in North America, Japan, and Sweden to nearby 60% in middle-income nations and lower than 40% in low-income nations.
  • Technological advancements such as the development of novel radioactive sources, remote after-loading systems, innovations in 3D imaging methods, and computerized treatment methods in molecular imaging are significant factors driving the market growth.
  • The molecular imaging market in the Asia Pacific region is likely to grow at the fastest rate in the forecast period due to the growing incidence and occurrence of chronic diseases, and better reimbursement policies.

Check Our Prices@ https://www.emergenresearch.com/select-license/271

Emergen Research has segmented the global molecular imaging market on the basis of product type, application, end-users, and region:

  • Product Type Outlook (Revenue, USD Billion; 2017-2027)
    • Positron Emission Tomography
    • Single Photon Emission Computed Tomography
    • Magnetic Resonance Imaging
    • Computed Tomography
    • Others
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Oncology
    • Cardiovascular Diseases
    • Neurology
    • Respiratory Diseases
    • Others
  • End-Users Outlook (Revenue, USD Billion; 2017-2027)
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/molecular-imaging-market

  • Regional Outlook (Revenue, USD Billion; 2017-2027)
    • North America
      1. US.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • MEA
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-molecular-imaging-market

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/80146

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.